1 – 10 of 10
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
- 2009
-
Mark
DEVELOPMENT OF IMMUNOHISTOCHEMICAL SURROGATES FOR PREDICTION OF BREAST CANCER PATIENT OUTCOME VIA HIGH-THROUGHPUT ANTIBODY GENERATION AND APPLICATION OF TISSUE MICROARRAY TECHNOLOGY: AN INITIAL REPORT
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
The Human Protein Atlas - a tool for pathology
(
- Contribution to journal › Letter
-
Mark
Systematic validation of novel breast cancer progression-associated biomarkers via high-throughput antibody generation and application of tissue microarray technology
2008) EBCC-6, European Breast Cancer Conference, 2008 In European Journal of Cancer Supplements 6(7). p.59-59(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Large-Scale Proteomics Analysis of Human Ovarian Cancer for Biomarkers
(
- Contribution to journal › Article
- 2006
-
Mark
From gene expression analysis to tissue microarrays - A rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies
(
- Contribution to journal › Article
- 2000
-
Mark
Phylogenetic evidence for novel and genetically different intestinal spirochetes resembling Brachyspira aalborgi in the mucosa of the human colon as revealed by 16S rDNA analysis
(
- Contribution to journal › Article
- 1998
-
Mark
Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations
(
- Contribution to journal › Article